These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8990505)

  • 1. Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis.
    van de Kerkhof PC; van Pelt H; Lucker GP; Steijlen PM; Heremans A
    Skin Pharmacol; 1996; 9(5):307-11. PubMed ID: 8990505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind vehicle-controlled study of R 68 151 in psoriasis: a topical 5-lipoxygenase inhibitor.
    Degreef H; Dockx P; De Doncker P; De Beule K; Cauwenbergh G
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):751-5. PubMed ID: 2189906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.
    de Jong EM; van Vlijmen IM; Scholte JC; Buntinx A; Friedman B; Tanaka W; van de Kerkhof PC
    Skin Pharmacol; 1991; 4(4):278-85. PubMed ID: 1724166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
    J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red-kerneled rice proanthocyanidin inhibits arachidonate 5-lipoxygenase and decreases psoriasis-like skin inflammation.
    Toda K; Tsukayama I; Nagasaki Y; Konoike Y; Tamenobu A; Ganeko N; Ito H; Kawakami Y; Takahashi Y; Miki Y; Yamamoto K; Murakami M; Suzuki-Yamamoto T
    Arch Biochem Biophys; 2020 Aug; 689():108307. PubMed ID: 32112739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis.
    Bischoff R; De Jong EM; Rulo HF; Sendagorta E; Czarnetzki BM; Van de Kerkhof PC
    Clin Exp Dermatol; 1992 Jan; 17(1):9-12. PubMed ID: 1424269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis.
    Van Pelt JP; De Jong EM; Seijger MM; Van Hooijdonk CA; De Bakker ES; Van Vlijmen IM; Parker GL; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1998 Sep; 139(3):396-402. PubMed ID: 9767282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
    Vahlquist A; Törmä H; Carlsson B
    Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benoxaprofen improves psoriasis. A double-blind study.
    Kragballe K; Herlin T
    Arch Dermatol; 1983 Jul; 119(7):548-52. PubMed ID: 6407402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
    Tanzer H; Braun C; Seidel M; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs.
    Müller K
    Arch Pharm (Weinheim); 1994 Jan; 327(1):3-19. PubMed ID: 8117187
    [No Abstract]   [Full Text] [Related]  

  • 12. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis.
    Bosman B
    Skin Pharmacol; 1994; 7(6):324-34. PubMed ID: 7946375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Lipoxygenase activation in psoriasis: a dead issue?
    Ford-Hutchinson AW
    Skin Pharmacol; 1993; 6(4):292-7. PubMed ID: 8198815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
    Weinblatt ME; Kremer JM; Coblyn JS; Helfgott S; Maier AL; Petrillo G; Henson B; Rubin P; Sperling R
    J Rheumatol; 1992 Oct; 19(10):1537-41. PubMed ID: 1334515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
    Müller K; Leukel P; Ziereis K; Gawlik I
    J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
    Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
    Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of topical indomethacin on psoriasis.
    Green CA; Shuster S
    Br J Clin Pharmacol; 1987 Sep; 24(3):381-4. PubMed ID: 3311105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
    Wiegrebe W; Müller K
    Skin Pharmacol; 1995; 8(1-2):1-24. PubMed ID: 7786521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial.
    Mayser P; Mrowietz U; Arenberger P; Bartak P; Buchvald J; Christophers E; Jablonska S; Salmhofer W; Schill WB; Krämer HJ; Schlotzer E; Mayer K; Seeger W; Grimminger F
    J Am Acad Dermatol; 1998 Apr; 38(4):539-47. PubMed ID: 9555791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm
    Mrowietz U; Szepietowski JC; Loewe R; van de Kerkhof P; Lamarca R; Ocker WG; Tebbs VM; Pau-Charles I
    Br J Dermatol; 2017 Mar; 176(3):615-623. PubMed ID: 27515097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.